Theravance Biopharma Inc (TBPH)
Sales/Maturities of Investments
$227.52M
TTM · Period ending: · USD
TBPH Sales/Maturities of Investments
Latest reported$227.52Mperiod ending
Latest reported$227.52Mperiod ending
TBPH TTM Sales/Maturities of Investments ($0.00 → $227.52M)
TTM Sales/Maturities of Investments
High-resolution chart · PNG
TBPH sales/maturities of investments history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 227,521,000 | |
| 206,375,000 | |
| 142,975,000 | |
| 133,339,000 | |
| 136,337,000 | |
| 144,230,000 | |
| 155,651,000 | |
| 99,762,000 | |
| 72,264,000 | |
| 54,618,000 | |
| 102,812,000 | |
| 152,124,000 | |
| 169,130,000 | |
| 201,733,000 | |
| 158,017,000 | |
| 173,504,000 | |
| 186,498,000 | |
| 219,198,000 | |
| 286,199,000 | |
| 339,414,000 | |
| 435,030,000 | |
| 400,625,000 | |
| 419,260,000 | |
| 301,246,000 | |
| 310,430,000 | |
| 323,105,000 | |
| 266,168,000 | |
| 363,910,000 | |
| 342,132,000 | |
| 378,091,000 | |
| 347,192,000 | |
| 293,925,000 | |
| 250,322,000 | |
| 244,881,000 | |
| 234,864,000 | |
| 213,592,000 | |
| 171,923,000 | |
| 110,680,000 | |
| 91,467,000 | |
| 96,319,000 | |
| 131,332,000 | |
| 150,296,000 | |
| 186,697,000 | |
| 192,808,000 | |
| 156,538,000 | |
| 119,912,000 | |
| 66,442,000 | |
| 32,276,000 | |
| 5,783,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |